Scutellaria baicalensis: Complete Guide to Botanical Source, Origin, Assay, Processing and Sourcing

Herb Wiki Editorial TeamLast updated 2026-10-29

AppearanceCross-section yellowish-white to yellow; centre of old roots decayed and hollow
AssayBaicalin ≥9.0% (Chinese Pharmacopoeia 2025, calculated on the dried drug)
Common gradesTiaopin (ziqin), kuqin (pianqin)
Test methodHPLC-UV 280 nm, methanol–water–phosphoric acid 47:53:0.2

Definition in One Sentence

Huangqin (Scutellaria baicalensis Georgi) is a perennial herb of the genus Scutellaria (Lamiaceae), used as medicine as its dried root. It is bitter and cold, entering the lung, gallbladder, spleen, large intestine and small intestine meridians; it clears heat and dries dampness, drains fire and resolves toxicity, stops bleeding and calms the fetus, and is one of the most frequently used herbs in heat-clearing formulas in Chinese medicine. Its marker compound is baicalin, with a legal minimum of 9.0% in the crude drug; the main active constituents also include baicalein, wogonoside and wogonin.

Botanical Source and Drug Identity

Whole plant of Scutellaria baicalensis
Figure 1. Whole plant of Scutellaria baicalensis (Lamiaceae; square stems, opposite leaves, purple-blue labiate flowers). Placeholder image, to be replaced with a photograph or illustration.
ItemDetail
Chinese nameHuangqin
Botanical nameScutellaria baicalensis Georgi
Family and genusLamiaceae, genus Scutellaria
Medicinal partDried root
Other namesShanchagen, huangjincha, tiaopin, kuqin, ziqin
Nature, flavour and meridiansBitter, cold; enters the lung, gallbladder, spleen, large intestine and small intestine meridians
ActionsClears heat and dries dampness, drains fire and resolves toxicity, stops bleeding, calms the fetus
Usual dose3–10 g
Pharmacopoeial markerBaicalin (C₂₁H₁₈O₁₁) ≥9.0%
Main active constituentsBaicalin, baicalein, wogonoside, wogonin, oroxylin A
Main producing areasHebei, Shanxi, Shaanxi, Gansu, Inner Mongolia
HarvestDug in spring and autumn

Huangqin and huangqi (Astragalus) are two different drugs and must never be mixed up: huangqin is a Lamiaceae plant whose root is used, with the flavonoid baicalin as marker; huangqi is a Fabaceae plant whose marker is the triterpenoid saponin astragaloside IV (CAS 84687-43-4). Chinese input methods frequently confuse the two characters; contracts and labels should always rely on the botanical name and CAS number.

Characteristics and Commercial Grades: Telling Tiaopin, Kuqin and Ziqin Apart

Cross-sections of tiaopin and kuqin
Figure 2. Comparison of crude drug characteristics: left, tiaopin (firm, yellowish-white cross-section); right, kuqin (hollow old root). Placeholder image, to be replaced with a photograph or illustration.

The pharmacopoeia sets no grades for the crude drug, yet the market divides it into more than a dozen specifications by root diameter, whether the bark has been tumbled off, and whether the root is solid or hollow. Without this vocabulary, quotes do not line up at all.

  • Tiaopin (ziqin): roots of shorter growing age, firm, with a solid yellowish-white cross-section. Traditionally regarded as acting more on large-intestine fire.
  • Kuqin (pianqin): old roots, hollow and decayed at the centre, darker in colour, with a "withered" cross-section. Traditionally regarded as acting more on lung fire. Extraction plants usually prefer solid tiaopin because yield per unit weight is higher.
  • Tumbled and untumbled: pharmacopoeial processing requires "sun-dry, then tumble off the coarse bark". Tumbled goods have a smooth yellowish-white surface; untumbled goods keep a rough brownish-yellow outer bark. Exporters and decoction-piece plants mostly want tumbled goods; extraction plants are relatively relaxed about it.
  • Unselected and selected: graded by diameter, uniformity and fines content. Common diameter brackets are 0.6–0.8 cm, 0.8–1.0 cm and above 1.0 cm; definitions differ between suppliers, so the sieve size and diameter must be written into the contract.

One practical rule: for goods of the same origin and diameter, a conspicuously low quote should first raise three suspicions — old stock, excess moisture, or extracted mare returned to the lot.

How diameter, tumbling and cleanliness convert into a comparable price, and how acceptance criteria should be written into a contract, see Grades and Specifications of Scutellaria baicalensis.

Growing Regions: From Chengde to Fuping

Traditionally, material from Chengde in Hebei is called "Rehe huangqin" and is recognised as a premium region; Shanxi, Shaanxi and Gansu are also major producing areas. Regional differences lie mainly in root shape and glycoside accumulation: assay can be matched, but impurity profiles and colour often differ.

Our crude drug comes from Laomiao Township, Fuping County, Weinan City, Shaanxi, on the dry loess tableland at the northern foot of the Weihe hills, where the soil is mainly huangmian loess under dryland management. Published reports for the region put baicalin at 12%–16% (Weinan Daily reported above 16% in 2025; a company survey in the region measured 12% in 2016), well above the pharmacopoeial floor of 9.0%.

A note on the word "daodi" (authentic-origin): Fuping is not a traditional daodi region in the historical literature, but its core cooperative was designated in 2021 as a member of the first batch of Shaanxi provincial demonstration bases for authentic medicinal material cultivation. The accurate wording is "provincial-level demonstration base for authentic medicinal material cultivation", supported by a designation document; a general claim to "daodi medicinal material" is a quality claim, and the two must not be conflated.

For a full account of growing conditions, the cooperative's organisation and batch traceability, see Fuping Scutellaria baicalensis: Origin, Cultivation Base and Batch Traceability.

Assay: 9.0% Is the Legal Floor, 12% Is a Cost Advantage

Baicalin content anchors every price for huangqin. It matters not only for compliance but for extraction economics: a few percentage points of assay make a real difference in output per tonne of feed on the same line.

  • Baicalin (446.36) hydrolyses to baicalein (270.24) with a theoretical mass yield of 60.5%;
  • one tonne of crude drug at 9.0% baicalin theoretically yields about 54 kg of baicalein;
  • on the same line, raising the raw material from 9% to 12% yields about 18 kg more baicalein per tonne of drug.

For baicalin's own properties, manufacture and specification grades, see Baicalin: A Complete Guide. This is what "origin" really means in a B2B context — not a cultural story, but the output difference per tonne of feed. Conversely, any quote below what mass balance allows should first be tested against the measured baicalin value of the raw material.

Test method: the pharmacopoeia assays baicalin by HPLC on a C18 column with a methanol/acetonitrile–water–phosphoric acid system and UV detection. Baicalin and baicalein share a conjugated flavonoid skeleton, so UV detection is sensitive and reliable — quite unlike saponins, which require evaporative light scattering detection. The method has a low barrier and good reproducibility.

Harvest, Primary Processing and "Sulfur-Free"

Huangqin is harvested in spring and autumn, as the pharmacopoeia specifies, but in practice the region harvests mainly in autumn, with concentrated digging after Frost's Descent, when the aerial parts have died back and dry matter in the root is at its peak. Two-and-a-half to three-year-old roots are the usual harvest age.

Primary processing: remove fibrous roots and soil → sun-dry or machine-dry → tumble off the coarse bark → grade. Tumbling, traditionally done with a tumbling machine or by hand, removes the outer cork layer to expose the yellowish-white xylem and create the commercial appearance.

Of the post-harvest steps, the one that really fixes the constituent profile is enzyme kill: endogenous enzymes in the fresh root hydrolyse baicalin to baicalein, so the glycoside/aglycone ratio is set before the material ever reaches the warehouse. For the process window, drying parameters and acceptance methods, see "Post-Harvest Handling of Scutellaria baicalensis: Enzyme Kill, Drying and the Glycoside/Aglycone Split".

Three process points directly determine quality:

  1. Drying speed: slow natural drying in wet weather raises the risk of glycoside hydrolysis and mould; material from cooperatives with drying capacity retains its constituents more consistently.
  2. Sulfur fumigation: formerly used against mould and for bleaching, it introduces sulfur dioxide residues. The pharmacopoeia sets an SO₂ limit, and export and dietary-supplement buyers generally require "sulfur-free". Always request SO₂ test data; do not accept the words "sulfur-free" alone.
  3. Moisture: in-house limits are usually ≤12%. Material with high moisture heats up and discolours in storage, and assay slowly declines.

Storage: keep in a ventilated, dry place, protected from damp and insects. In hot, humid summer regions, humidity-controlled storage with regular restacking is recommended.

Processing: Raw, Wine-Fried and Charred — Three Forms, Three Uses

Part I of the 2025 Chinese Pharmacopoeia includes three processed forms: raw huangqin, wine-fried huangqin and charred huangqin. They differ both in processing method and in where they are applied.

Processed formKey processing stepsTraditional preference of use
Raw huangqinRemove impurities, wash, soften thoroughly, cut into thin slices, dryStrong in clearing heat, drying dampness, draining fire and resolving toxicity; tends to act on the upper burner
Wine-fried huangqinMix evenly with yellow rice wine, let it soak through, stir-fry until slightly drySoftens the bitter-cold property and guides the drug upward; mostly used to clear lung heat
Charred huangqinStir-fry over high heat until the surface is charred brown and the interior brownish-yellowClears heat and stops bleeding; used for vomiting and epistaxis due to heat in the blood

For extractors and formulators, processing is not merely a "traditional idea": heat and excipients change the ratio of glycosides to aglycones. Whether raw or wine-fried material is used as extraction feed changes both yield and constituent profile, and this must be settled before developing a compound formulation — the two are not interchangeable by default.

Identification and Adulterants

The pharmacopoeia recognises only Scutellaria baicalensis. Common substitutes from the same genus on the market include S. amoena, S. rehderiana and S. viscidula: similar in appearance but different in constituent profile.

Key identification points:

  • Macroscopic: authentic material has a yellowish-white to yellow cross-section with a decayed centre in old roots; substitutes usually differ in cross-section colour, texture and odour;
  • Physicochemical: TLC and baicalin assay are the most direct discriminators; an abnormally low assay or a fingerprint missing the main peak should raise doubts about botanical source;
  • Microscopic: powder microscopy shows stone cells, vessels and starch grains in a characteristic combination, useful as a supplement.

The simplest sourcing rule is to require a botanical-source declaration, an assay report and a fingerprint chromatogram. If the three do not agree, reject the lot.

Pharmacology: Evidence at the Herb Level

The pharmacology of huangqin is the result of multi-component synergy, contributed mainly by baicalin, baicalein, wogonin and wogonoside. The mechanisms below rest largely on in vitro and animal studies; human clinical evidence is limited.

  • Antibacterial and anti-inflammatory: inhibits a range of bacteria and fungi; inhibits the NF-κB pathway and reduces release of inflammatory cytokines. Baicalein is a classic 12/15-lipoxygenase inhibitor.
  • Antipyretic: one modern counterpart of traditional "clearing heat", associated with inhibition of endogenous pyrogens.
  • Antiviral: in vitro activity against influenza virus and HBV has been reported; no clinical conclusions yet.
  • Hepatoprotective and choleretic: lowers transaminases and reduces liver injury — one reason huangqin appears so often in liver and gallbladder formulas.
  • Hypotensive and sedative: shown in animal studies; clinical evidence is limited.
  • Haemostatic and fetus-calming: traditional actions corresponding to the charred form and to compound use; mechanistic research is relatively thin.

Compliance note: the indications on this herb page are strictly confined to the pharmacopoeia and Chinese medicine theory. They must not be rewritten as dietary-supplement function claims or disease-treatment claims.

Regulation and Standards: Three Tracks — Decoction Pieces, Extracts and Export

Huangqin as a crude drug, as decoction pieces, as an extract or as an export commodity follows different compliance routes; the same lot put to a different use may no longer comply.

  • Crude drug and decoction pieces: governed by the "Scutellaria baicalensis" monograph in Part I of the 2025 Chinese Pharmacopoeia; assay, moisture, ash, extractives, sulfur dioxide, heavy metals and pesticide residues all have general-chapter requirements. Decoction pieces must meet the processing specification, and manufacture requires the appropriate licences.
  • Extracts: there is no separate pharmacopoeial monograph for Scutellaria extract; most are made to enterprise or industry standards. Use in dietary supplements must meet the ingredient catalogue and the registration or filing requirements.
  • Export: the Japanese Pharmacopoeia includes huangqin (オウゴン). The EU and the US mostly regulate it as a food supplement or herbal product, depending on form and claims, and each case must be confirmed against the target market.
  • Food use: huangqin is not listed in China's catalogue of substances that are both food and medicinal material; ordinary food use requires caution — do not assume that "medicine and food share one origin".

Sourcing and QC Checklist

QC for huangqin splits into two layers: eight documents that must be complete on arrival, and five common traps to watch for even when the paperwork is complete.

The eight mandatory items

  1. Botanical source and origin declaration (S. baicalensis, specific region);
  2. Baicalin assay (HPLC, with chromatogram);
  3. Moisture (in-house limit usually ≤12%);
  4. Sulfur dioxide residue (critical for export and dietary supplements);
  5. Heavy metals (lead, cadmium, arsenic, mercury, copper);
  6. Pesticide residues (pharmacopoeial general-chapter limits);
  7. Total ash and acid-insoluble ash (to detect soil adulteration);
  8. Mould, insect damage and aflatoxins (mandatory on arrival from hot, humid regions).

Five common traps

  • Old stock: material stored more than two years is dark and faint in odour, with lower assay, yet the report may still pass;
  • Excess moisture: price cut through "weight gain"; the goods heat up and discolour in storage;
  • Spent mare returned: extracted huangqin re-dried and blended in, with very low assay that an assay test exposes;
  • Sulfur fumigation: abnormally bright appearance and a sour odour; SO₂ data is the key;
  • Botanical substitution: another species of the same genus passed off as authentic, requiring fingerprint evidence.

FAQ

Q1: What is the difference between huangqin and huangqi?

Two different drugs. Huangqin is Lamiaceae, root used, marker baicalin (a flavonoid); huangqi is Fabaceae, marker astragaloside IV (a triterpenoid saponin, CAS 84687-43-4). The Chinese characters are often confused; rely on the botanical name.

Q2: How are baicalin and baicalein related?

Glycoside and aglycone. Baicalin is the 7-O-glucuronide of baicalein, present at higher levels in the crude drug and more water-soluble; baicalein is the active aglycone after hydrolysis. The two interconvert in vivo.

Q3: Which is better, tiaopin or kuqin?

It depends on the use. Tiaopin (ziqin) is firm with a higher yield and is more common in extraction and decoction-piece plants; kuqin is the hollow old root, traditionally used to clear lung fire. Neither is absolutely superior; the quote must match the use.

Q4: Why is huangqin "tumbled"?

Tumbling removes the outer cork and exposes the yellowish-white xylem, which underpins the commercial appearance and grade, and also makes the internal texture easier to judge. The tumbling rate affects yield, so the definition should be stated when purchasing.

Q5: How much does the difference between 9% and 12% baicalin cost?

There is no single answer, but it can be calculated: at a 60.5% hydrolysis yield, 12% material gives about 18 kg more baicalein per tonne. A three-point assay difference is a real output difference at the extraction end.

Q6: How is "sulfur-free" verified?

Look at sulfur dioxide residue data, not marketing language. The pharmacopoeia sets an SO₂ limit, export customers usually demand a stricter in-house value, and the method and limit should be agreed in the contract.

Q7: Can fresh and old stock be told apart visually?

Yes. Fresh stock is bright in colour, strong in odour and freshly yellow in cross-section; old stock is dark, faint and brittle. But assay and moisture data remain the most reliable; appearance is only a first screen.

Q8: Can huangqin be used in ordinary food?

It is currently not on the catalogue of food-and-medicine substances, so ordinary food use requires caution; dietary supplements follow the registration and filing requirements, and cosmetic extracts must use the names given in the ingredient catalogue.

Q9: Is huangqin grown on our own base always high in assay?

Not necessarily. Assay depends on variety, age, soil, harvest time and drying conditions, and varies between years on the same plot. The value of a base lies in control and traceability, not in exemption from testing.

Q10: How do fresh and dry material convert?

The fresh-to-dry ratio for huangqin is usually between 2.5:1 and 3:1, varying with moisture content and plant part. Before negotiating, confirm whether the price is for fresh or dry material, or the difference will be misread as a market move.

References and Search Strategies

  1. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (2025 edition, Part I), monograph "Scutellaria baicalensis". Beijing: China Medical Science Press, 2025.
  2. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (2025 edition, Part IV), General Chapter 0212 General Rules for the Testing of Crude Drugs and Decoction Pieces; General Chapter 0512 High-Performance Liquid Chromatography.
  3. Reviews of the chemical constituents and pharmacology of Scutellaria baicalensis: PubMed search "Scutellaria baicalensis"[Title/Abstract] AND review[pt], limited to the last five years.
  4. Processing and constituent changes in huangqin: search Scutellaria baicalensis AND (processing OR stir-frying OR wine) AND flavonoid.
  5. Public sources for the Fuping region are listed at the end of Fuping Scutellaria baicalensis: Origin, Cultivation Base and Batch Traceability.

Items 3 and 4 are search paths rather than specific citations; use them to locate and verify the original papers.

Disclaimer

This article is technical material on the crude drug, intended for growers, buyers, QC and R&D staff. It does not constitute medical advice, prescribing guidance or a compliance opinion. Assay values, limits and regulatory information change as standards are revised; for actual transactions and filings, rely on the current official standard, the agreed contract and third-party test reports.